Kits Eyecare (TSE:KITS) has released an update.
KITS Eyecare has reported a remarkable 34% increase in revenue for the third quarter of 2024, reaching $41.9 million, driven by a significant surge in glasses sales and operational efficiencies. The company has also achieved its eighth consecutive quarter of positive adjusted EBITDA, underscoring its successful business strategy and market expansion.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.
